Completed PHASE2 INTERVENTIONAL NCT00004796

Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis

Sponsor: National Center for Research Resources (NCRR)

Conditions Cirrhosis Hepatic Encephalopathy Portal Hypertension

Interventions lactulose

Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Nov 30, 1994 Completion: Feb 28, 1997

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004796, this PHASE2 trial focuses on Cirrhosis and Hepatic Encephalopathy and remains completed. Sponsored by National Center for Research Resources (NCRR), it has been updated 5 times since 1994, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Nov 1994

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Center for Research Resources (NCRR)
Northwestern University

Data source: Office of Rare Diseases (ORD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.